ClinicalTrials.Veeva

Menu

Speech, Linguistic and Acoustic Markers in Parkinson's Disease (SLAM-PD)

U

University of Massachusetts, Worcester

Status

Completed

Conditions

Parkinson Disease
Speech
Cognitive Impairment, Mild

Treatments

Diagnostic Test: Cognitive Battery
Behavioral: Voice, Speech and Language Analysis
Behavioral: Questionnaires and Clinical Assessments
Genetic: DNA Analysis

Study type

Observational

Funder types

Other
Other U.S. Federal agency
NIH

Identifiers

NCT04273672
5K23DC016656 (U.S. NIH Grant/Contract)
H00011523

Details and patient eligibility

About

The Investigators aim to identify speech and language markers that provide information on cognitive function and predict cognitive decline in Parkinson's disease. The Investigators will administer speech tasks and cognitive assessments to participants with Parkinson's disease and healthy controls. The Investigators will also explore the associations between genetic factors and speech and cognitive status in Parkinson's disease.

Enrollment

58 patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Parkinson's Disease (or healthy control)
  • Disease duration ≥ 2 years
  • Mild cognitive impairment or normal cognition

Exclusion criteria

  • Diagnosis of dementia (MoCA <21)
  • Adults unable to consent
  • Age < 18
  • Pregnant women
  • Prisoners
  • Non-English speakers
  • Any neurological disorder other than PD
  • Deep brain stimulator placement
  • Severe, unstable psychiatric disorder
  • Unintelligible speech due to effects of PD
  • Visual acuity or color vision impairment that would interfere with cognitive testing
  • Other voice, speech or swallowing disorders or history of surgery involving palate/nasopharynx/larynx/vocal cords

Trial design

58 participants in 2 patient groups

Parkinson's Disease
Description:
Subjects with Parkinson's Disease
Treatment:
Genetic: DNA Analysis
Behavioral: Questionnaires and Clinical Assessments
Behavioral: Voice, Speech and Language Analysis
Diagnostic Test: Cognitive Battery
Control
Description:
Subjects without Parkinson's Disease
Treatment:
Behavioral: Questionnaires and Clinical Assessments
Behavioral: Voice, Speech and Language Analysis
Diagnostic Test: Cognitive Battery

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

Christina Manxhari, BA; Kara Smith, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems